A growing amount of Q&R applies to creating pharmaceuticals. Pharmaceutical manufacturers prefer ingredients developed with compliance that exceeds legal requirements. As the Q&R landscape evolves and its complexity deepens, it becomes increasingly challenging for pharmaceutical ingredient manufacturers to achieve a consistently high standard of Q&R. Corbion Purac leads the world in production of lactic acid and derivatives for a wide range of pharmaceutical products. Through continuous investment in Q&R, it embedded practices into its culture to improve business performance. Some of the challenges already conquered and implications of future changes in the Q&R landscape are discussed.